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Abstract—One field of application of Big Data and Artificial 
Intelligence that is receiving increasing attention is the 
biomedical domain. The huge volume of data that is customary 
generated by hospitals and pharmaceutical companies all over 
the world could potentially enable a plethora of new applications. 
Yet, due to the complexity of such data, this comes at a high cost. 
We here review the activities of the research group composed by 
people of the Universidad Politécnica de Madrid and the Hospital 
Universitario Puerta de Hierro de Majadahonda, Spain; discuss 
their activities within two European projects, IASIS and 
BigMedilytics; and present some initial results. 
Keywords—Artificial Intelligence; Big Data; biomedical 
problems; Electronic Health Records; medical imaging 
I.  INTRODUCTION 
Since it was initially coined, the term Big Data is 
having an enormous impact in our society. It has 
gained such importance that governments around the 
world had to acknowledge its relevance in contexts 
such as politics, military, law, or management. 
Accordingly, the European Union followed this 
trend by creating specific associations and 
organizations dealing with the impact generated by 
Big Data and surrounding terms, such as Machine 
Learning, Artificial Intelligence, etc. If Big Data 
impacted several fields, the archetype is medicine, 
as it was soon understood that the incredible amount 
of routinely generated data could be used for very 
different purposes. Accordingly, the European 
Commission has launched several initiatives and 
calls aimed at funding projects with the objective of 
studying what are the insights that the extraction, 
analysis and use of medical data can provide. 
The group of Mineria de Datos y Simulación 
(MIDAS) (Data Mining and Simulation) of the 
Universidad Politécnica de Madrid (UPM) has 
followed very closely these movements. With more 
than 20 years of experience in applying Data Mining 
(DM) techniques to several fields, the current 
MIDAS team started several years ago to move its 
research area to the biomedical domain. Its technical 
expertise has been complemented by the 
collaboration with the medical oncology department 
of the Hospital Universitario Puerta de Hierro de 
Majadahonda (HUPHM), Madrid, Spain. This has 
resulted in the involvement in several projects in the 
context of Big Data and Artificial Intelligence in the 
medical field, with two of them funded by the 
European Commission. 
This contribution aims at describing the MIDAS / 
HUPHM team, the expertise of their members, and 
the techniques by them used. A special focus is 
given to the two European projects in which they 
participate, with an analysis of their objectives and 
characteristics. Some of the results that have been 
obtained so far in these projects are also presented, 
as well as other related initiatives. 
II. THE TEAM 
The meaningful application of Big Data 
techniques to the biomedical domain requires the 
convergence of two very different types of expertise: 
the knowledge of data managing and analysis on one 
hand and of the medical science on the other. This 
need buttressed the creation of collaboration 
between MIDAS and HUPHM, in which each 
partner contributes as described below. 
A. Universidad Politécnica de Madrid 
The MIDAS group is responsible of tasks related 
with the extraction of knowledge from medical 
unstructured data, both in the form of text 
(electronic health records) and image (CT/PET 
images). The main people involved are: 
 Ernestina Menasalvas Ruiz: Prof. 
Ernestina Menasalvas is a Full Professor 
at the “Escuela Técnica Superior de 
Ingenieros Informáticos” in UPM. She is 
the principal investigator of the projects 
described below, and is in charge of the 
global supervision as well as of tasks in 
the context of data understanding of text 
data and of the validation of the results. 
 Consuelo Gonzalo Martin: Prof. Consuelo 
Gonzalo is an Associate Professor at 
“Escuela Técnica Superior de Ingenieros 
Informáticos” in UPM. She is the leader 
of the sub-team inside MIDAS involved 
in image processing, analysis and 
understanding. Her main activities include 
the coordination and supervision of all 
tasks related to information extraction and 
structuring, as well as knowledge 
generation from CT/PET images. 
 Alejandro Rodríguez González: Prof. 
Alejandro Rodríguez is an Associate 
Professor at the “Escuela Técnica 
Superior de Ingenieros Informáticos” in 
UPM and the Principal Investigator of the 
Medical Data Analytics Laboratory at 
Center for Biomedical Technology 
(CTB). He supervises all efforts related to 
Natural Language Processing (NLP) 
tasks.  
 Massimiliano Zanin: Dr. Massimiliano 
Zanin is a post-doctoral researcher at 
Center for Biomedical Technology at 
UPM. His main tasks include the 
supervision of the technical team 
developing the technical pipeline, and 
support the work of Prof. Rodríguez and 
Prof. Menasalvas. 
 Juan Manuel Tunas: D. Juan Manuel 
Tunas is a researcher responsible for the 
analysis and post-processing of the NLP 
pipeline results. 
B. Hospital Universitario Puerta de Hierro-
Majadahonda 
Hospital Universitario Puerta de Hierro- 
Majadahonda is located in Madrid, Spain. This 
hospital, and more specifically, the medical 
oncology department, is in charge of providing the 
definition of the use cases and KPIs regarding the 
studied pathologies; the required data (electronic 
health records and images); and, more generally, the 
expertise necessary for the execution of the projects. 
The main people involved and their associated areas 
of responsibility are: 
 Mariano Provencio: Medical Oncologist, 
Chief of Medical Oncology Department 
at Puerta de Hierro University Hospital, 
Full Professor, School of Medicine at 
Autonoma University of Madrid and 
Scientific Director of the Research 
Institute at Puerta de Hierro University 
Hospital. He is the principal investigator 
of the European projects described below, 
responsible for the Lung Cancer Pilot. 
 Maria Torrente: Medical Doctor and PhD, 
responsible of international medicine 
programs in the Medical Oncology 
Department at Puerta de Hierro 
University Hospital. Associate Professor, 
School of Medicine, Francisco de Vitoria 
University, Madrid. Coordinator of 
national and international research 
projects focused on clinical oncology.  
 Fabio Franco: Medical oncologist and 
PhD, within the Lung cancer group in the 
Medical Oncology Department at Puerta 
de Hierro University Hospital. 
 Virginia Calvo: Medical oncologist and 
PhD, within the Lung cancer group in the 
Medical Oncology Department at Puerta 
de Hierro University Hospital. 
 Beatriz Nuñez: Medical oncologist and 
attending physician in the Medical 
Oncology Department at Puerta de Hierro 
University Hospital. 
III. PROJECTS 
As previously introduced, the MIDAS / HUPHM 
group is participating in various projects applying 
Big Data and Artificial Intelligence to the medical 
domain. Two of them, both funded by the H2020 
programme, are described below. 
A. IASIS 
Integration and analysis of heterogeneous big 
data for precision medicine and suggested treatments 
for different types of patients (IASIS)
1
 is a Research 
and Innovation Action (RIA) funded by European 
Commission, within its H2020 programme, and 
under the call "SC1-PM-18-2016 - Big Data 
supporting Public Health policies
2
". This call 
targeted projects dealing with the problem of 
acquiring, managing, sharing, modeling, processing 
and exploiting huge amount of data within the 
medical domain, with the goal of developing 
solutions to support public health authorities. 
Aligned with the goal defined in the call, IASIS 
project "seeks to pave the way for precision 
medicine approaches by utilizing insights from 
patient data. It aims to combine information from 
medical records, imaging databases and genomics 
data to enable more personalized diagnosis and 
treatment approaches in two disease areas – lung 
cancer and Alzheimer’s disease". 
                                                 
1
 http://project-iasis.eu/ 
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https://cordis.europa.eu/programme/rcn/700320_en.
html 
At the current stage of development, IASIS is 
primarily focusing in an application to lung cancer, 
being the one on the Alzheimer domain planned for 
the following months. For this reason, the detailed 
description of the project objectives are here focused 
on the lung cancer domain. 
IASIS aims to provide answers that can be 
relevant and effective for the medical practitioners. 
The main aims regarding lung cancer include: 
• Obtaining descriptive and predictive 
patterns to improve overall survival 
• Early detection of relapse and early 
palliative care initiation, and reducing 
overtreatments, comparing retrospective 
datasets with new datasets obtained from 
our EHR System. 
• Implementation of algorithms that reduce 
drug-drug interactions 
• Risk stratification of lung cancer patients 
(treatment selection based on 
comorbidity index, family history, risk 
factors.). 
In this context, the main use cases that have been 
defined in the lung cancer domain include: 
 Identifying specific patterns in long 
surviving lung cancer patients, analysing 
all the key factors found that may 
associate to long survival, and compare 
long-survivors with the rest of the 
patients, in order to look for specific 
patterns (natural and family history, 
treatments, response to treatments, 
toxicities, comorbidities and molecular 
mechanisms). 
 Search for risk and predictive factors for 
lung cancer in the study population 
 Analyse the effectiveness of tyrosin-
kinase inhibitors (TKI) in mutated lung 
cancer patients (EGFR, ALKt, ROS-1), 
and look for a possible correlation 
between toxicities and type/duration of 
the TKI treatment 
 
The Project is coordinated by National Centre for 
Scientific Research "Demokritos" (NCSR) in 
Greece. Beyond UPM and HUPHM, additional 
partners include: the St. George's Hospital Medical 
School (UK); Alzheimer's Research (UK); Grupo 
español de investigación en cáncer de pulmón 
(Spain); the Centro de Regulación Genómica (CRG) 
(Spain); the university system of Maryland 
foundation (USA); and the Gottfried Wilhelm 
Leibniz Universitaet Hannover (Germany). 
B. BigMedilytics 
Big Data for Medical Analytics (BigMedilytics) 
is an Innovation Action (IA) funded by European 
Commission, within its H2020 programme, and 
under the call "Leadership in enabling and 
industrial technologies - Information and 
Communication Technologies (ICT)”3. The projects 
funded under this call are also known as large-scale 
pilot projects. The aim of such initiative, in line with 
the flagship initiative 'Digital Agenda for Europe', 
includes "enable[ing] Europe to support, develop 
and exploit the opportunities brought by ICT 
progress for the benefits of its citizens, businesses 
and scientific communities." 
BigMedilytics goals include "the transformation 
of Europe’s Healthcare sector by using state-of-the-
art Big Data technologies to achieve breakthrough 
productivity in the sector by reducing cost, 
improving patient outcomes and delivering better 
access to healthcare facilities simultaneously, 
covering the entire Healthcare Continuum – from 
Prevention to Diagnosis, Treatment and Home Care 
throughout Europe." BigMedilytics is coordinated 
by Philips (Netherlands) and the consortium is 
composed of 35 partners from 11 different countries. 
Due to the size of the project and the consortium, its 
organization is divided in several pilots, focusing on 
the following medical areas/diseases: Comorbidities, 
kidney disease, diabetes, asthma/COPD, heart 
failure, prostate cancer, lung cancer, breast cancer, 
stroke, sepsis, asset management workflows and 
radiology workflows. 
As in the IASIS project, the UPM / HUPHM 
team is working in the lung cancer pilot. The aim 
and KPIs defined in this pilot differ from the IASIS 
project as in IASIS we are more focused in the 
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https://www.cordis.europa.eu/programme/rcn/6641
47_en.html 
disease and finding answers to clinical questions that 
may help us improve our daily clinical practice, 
while Bigmedilytics is focused in optimizing not 
only the patient´s management, but also the medical 
oncology department´s workflow by: 
• Increase of early diagnosis: identification 
of patients at risk of developing lung 
cancer 
• Reducing the cost per patient (reduction 
of visits to ER, readmissions, reduction of 
toxicities). 
• Reducing toxicity rates specially in 
complex patients. 
• Improving the patients satisfaction: 
increasing patient´s empowerement and 
information. 
 
The additional partners involved in the lung 
cancer pilot of the BigMediliytics project include the 
National Centre for Scientific Research 
"Demokritos" (Greece), and the Gottfried Wilhelm 
Leibniz Universitaet Hannover (Germany). 
IV. DATA SOURCES 
The main dataset used in both projects is provided 
by HUPHM to UPM and includes an anonymized 
dataset containing data from the Electronic Health 
Records of 700 lung cancer patients (171.891 
clinical notes and 7.021 clinical reports). 
A. IASIS 
The IASIS’ lung cancer disease area involves the 
analysis of two different types of unstructured data: 
Text: The text in the IASIS project came from the 
Electronic Health Records (EHR) provided by 
HUPHM, describing patients diagnosed with lung 
cancer. 
Image: A basic set of images has been provided by 
HUPHM, for patients with nodules diagnosed as 
malignity/non-malignity - in a further step, the 
analysis will be extended to different kinds of 
malignity. In addition to this, several open access 
image data bases have been used, including the 
Lung Image Database Consortium image collection 
(LIDC-IDRI
4
), NSCLS-Radiomics
5
, and LUNA
6
. 
B. BigMedilytics 
 
In a similar manner, the lung cancer pilot in 
BigMedilytics will be executed with similar data 
(electronic health records provided in IASIS will be 
also available in BigMedilytics). The main 
differences in terms of data in BigMedilytics 
include: 
 Image data are not provided: the analysis of 
the lung cancer information in BigMedilytics 
is not focused on the analysis of medical 
images. 
 New structured data are provided, based on 
the specific goals and KPIs of the project: 
1. Oncology calls: The HUPHM 
provided a set of files containing 
information about a service for the 
telephonic attention of cancer 
patients. This service is not 
exclusively focused on lung cancer 
patients. The data recorded contain 
information about the number of calls 
performed by each patient and their 
dates, reasons, and related 
information. 
2. Oncology app: HUPHM developed a 
mobile application
7
 with the aim of 
providing cancer patients with 
information and personalized advices 
about their disease.  
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https://wiki.cancerimagingarchive.net/display/Publi
c/NSCLC-Radiomics 
6
 https://luna.grand-challenge.org 
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https://play.google.com/store/apps/details?id=org.id
iphim.oncoapp 
V. TECHNICAL WORK 
As previously explained, both projects (IASIS 
and BigMedilytics) deal with three types of data: 
 Textual information (Electronic Health 
Records), 
 Medical images, and 
 Structured data (Call service and mobile 
app). 
For a better understanding of the main 
technological goals, the methodology associated to 
each one of these types is described below. 
A. Textual information 
 
The main goal of UPM in this project in terms of 
the textual information implies: 
 To analyze structure free text. UPM is 
developing a framework called CliKES 
(Clinical Knowledge Extraction System) 
based on the Apache UIMA 
infrastructure. The system is in charge of 
performing most of the tasks of the 
classical NLP pipeline, starting with the 
clinical notes and reports of the patients’ 
EHRs, to end up with a database 
containing all relevant information. The 
novelty behind the current work is based 
on the application of NLP techniques to 
EHR in Spanish, along with the creation 
of ad-hoc annotators focused on 
identifying terms referred to lung cancer 
domain (including treatments, mutations, 
etc.). 
 To analyze the structured data yielded by 
the CliKES pipeline, to synthesize useful 
information for the physicians according 
to the use cases definition. Specifically, 
physicians aim at getting relevant 
information about possible co-
occurrences in their lung cancer patients, 
as well as at trying to find specific 
correlations between them.   
 To provide the results to the IASIS and 
BigMedilytics consortium, more 
specifically to the Hannover team, for the 
creation of knowledge graphs with the 
information of those patients. Both 
projects aim at creating a semantic-based 
version of the data, to allow complex 
queries with the processed patient data, 
medical literature knowledge provided by 
NCSR, and genetic information (in IASIS 
only, provided by CRG). 
B. Medical images 
 Structuring image data. Two types of 
features have been extracted from the 
available images: semantic and agnostic 
features. A python script module has been 
developed to extract the former ones from 
CT images in DICOM format. The principal 
tool used in this module has been Py-
Radiomics (Van Griethuysen et al., 2017), 
but also other proprietary libraries. Pre-
trained Convolutional Neural Networks 
(CNN) models have been used for the 
extraction of agnostic features. The most 
usual approach of feeding these models is by 
means of a sliding cube through the 3-D 
images; yet, this was here completely 
unviable from a computational point of view. 
In order to drastically reduce the volume of 
data to be processed, while minimizing the 
loss of information, this process has been 
implemented at a supervoxel level (Gonzalo-
Martín et al, 2016).   
 In a future phase, the features extracted from 
images will be used to generate models 
allowing yielding useful knowledge for 
physician, such as predicting the survival 
time of lung cancer patients. 
 Finally, provide the results to the IASIS 
consortium, more specifically to Hannover 
team, for the creation of knowledge graphs 
with the information of those patients.  
C. Structured data 
Two specific data sources were part of 
BigMedilytics’ lung cancer: HUPHM Oncology call 
service and OncoApp mobile application. The aim 
of UPM is to integrate the data generated by these 
services (which is already in a structured form) to 
improve the analysis that will be performed; more 
specifically, to find correlations and patterns in the 
patients based on their clinical information and their 
behavior in using these services. 
VI. CONCLUSIONS 
As has been shown for all the types of data 
explained in this paper, a clear relationship is 
present between the aim of these projects and the 
application of Artificial Intelligence and Machine 
Learning techniques. On one hand, both projects 
have to deal with unstructured data (in image or text 
form), which require the application of complex 
techniques and strategies for their handling. In the 
case of text data, UPM is researching and 
developing a tool named CliKES, aimed at 
processing Electronic Health Records in Spanish, 
something that although has been under 
development and research by several groups in 
Spain, is still an on-going task. The nature of the 
data provided by each hospital and the 
corresponding processing, the problems associated 
to the narratives written by each physician, the 
identification of events, the detection of negation or 
acronyms in the correct context, the recognition of 
entities and the appropriate identification of 
information and the subject that belong to are, 
among other problems, still open problems in the 
field of Natural Language Processing, and this 
despite the large amount of work in the field. Here it 
is important to emphasize how the machine learning 
techniques play a very important role in several of 
the tasks of the NLP pipeline, and how important is 
to find accurate models to create accurate NLP 
systems. 
Finally, both projects have to deal with structured 
data. In this context, UPM is mainly working on the 
application of Data Mining techniques to find 
important insights and evidences within the data. 
The amount of data, as well as its diversity (textual, 
image, call service, mobile application), requires 
huge efforts in terms of structuring, processing and 
cleaning. These efforts are done with the objective 
of having data with enough quality, to subsequently 
apply the correct data mining techniques and finding 
evidences based on the use cases, these latter 
defined by the physicians as well as the associated 
KPIs.  
A comprehensive characterization of lung cancer 
tumor signatures is critical for a correct diagnosis 
and optimal treatments. As precision medicine is 
practiced more widely, one of the main challenges 
is the integration and analysis of clinical data,  
opening new opportunities for more accurate 
diagnosis, more sensitive and frequent disease 
monitoring and more personalized therapeutic 
strategies, at the level of the individual. 
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